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ABSTRACT
Introduction The COVID-19 pandemic has affected
communities of colour the hardest. Non-Hispanic
black and Hispanic pregnant women appear to have
disproportionate SARS-CoV-2 infection and death rates.
Methods and analysis We will use the socioecological
framework and employ a concurrent triangulation, mixed-
methods study design to achieve three specific aims:
(1) examine the impacts of the COVID-19 pandemic on
racial/ethnic disparities in severe maternal morbidity and
mortality (SMMM); (2) explore how social contexts (eg,
racial/ethnic residential segregation) have contributed to
the widening of racial/ethnic disparities in SMMM during
the pandemic and identify distinct mediating pathways
through maternity care and mental health; and (3)
determine the role of social contextual factors on racial/
ethnic disparities in pregnancy-related morbidities using
machine learning algorithms. We will leverage an existing
South Carolina COVID-19 Cohort by creating a pregnancy
cohort that links COVID-19 testing data, electronic health
records (EHRs), vital records data, healthcare utilisation
data and billing data for all births in South Carolina (SC)
between 2018 and 2021 (>200 000 births). We will also
conduct similar analyses using EHR data from the National
COVID-19 Cohort Collaborative including >270 000 women
who had a childbirth between 2018 and 2021 in the USA.
We will use a convergent parallel design which includes
a quantitative analysis of data from the 2018–2021 SC
Pregnancy Risk Assessment and Monitoring System
(unweighted n>2000) and in-depth interviews of 40
postpartum women and 10 maternal care providers to
identify distinct mediating pathways.
Ethics and dissemination The study was approved
by institutional review boards at the University of SC
(Pro00115169) and the SC Department of Health and
Environmental Control (DHEC IRB.21-030). Informed
consent will be provided by the participants in the in-depth
interviews. Study findings will be disseminated with key
stakeholders including patients, presented at academic
conferences and published in peer-reviewed journals.

STRENGTHS AND LIMITATIONS OF THIS STUDY
⇒ This study investigates whether the COVID-19 pan-

⇒

⇒

⇒

⇒

demic, structural racism and racial discrimination
have contributed to the racial/ethnic disparities in
severe maternal morbidity and mortality in the USA.
This study employs a state-of-the-art design (ie,
a convergent parallel design) and machine learning models to rigorously examine the questions of
interest.
This study will use a large-scale population-based
cohort study concurrently for both South Carolina
and the USA, which will innovatively integrate
COVID-
19-
related clinical, surveillance, electronic
health record, and geospatial data at community,
healthcare institutions and system/policy levels.
The effects of both county-level and ZIP-code-level
social contexts will be calculated at the maternal
residence location.
The stagnant residential social contexts might not
reflect their long-term exposures to neighbourhood
structural racism.

INTRODUCTION
Annually, nearly 60 000 women experience
severe maternal morbidity (SMM) (ie, unexpected complications of labour and delivery)
and mortality (SMMM).1 2 Between 1993 and
2014, SMMM rates in the US tripled from 49.5
to 146.6 per 10 000 childbirths.3 For every 70
US women who experienced an SMM, one
died during or immediately after pregnancy.4
The SMM occurrences have also led to significant short-term or long-term clinical impacts
on women’s health5 and added significant
costs to women, their families, taxpayers and
the healthcare system.6–8
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Non-
Hispanic black (hereafter, black) women experience a threefold to fourfold risk of pregnancy-related
deaths compared with non-Hispanic white women (hereafter, white).9 10 Black and Hispanic women were up to
110%more likely to experience SMMM,2 despite their
younger maternal age (often a protective factor for
SMMM) as compared with non-Hispanic white women.
Such racial/ethnic disparities in SMMM rates have
persisted for over a decade—with increasing rates among
all race/ethnic groups.11 These SMMM rates are unevenly
distributed socioeconomically and geographically—with
the highest rate among low-income women who delivered
at hospitals in the Deep South states.2 12–14
The unprecedented COVID-19 pandemic hit communities of colour the hardest.15–17 Pregnant Black
and Hispanic women experienced disproportionate
COVID-
19 infection and death rates.18–20 The impacts
of COVID-
19 on SMMM remain unclear. During the
pandemic, as unemployment, income instability and
financial stress have affected many US families, Black
and Hispanic families have faced even higher hardship
rates.21 These disproportionate consequences reflect
long-standing inequities, often stemming from structural
racism and discrimination (eg, residential segregation,
poverty, inadequate education, unemployment and lack
of home ownership).22 23 These inequities can lead to
uneven access to quality healthcare, psychosocial stress
and unhealthy lifestyles among women of colour, which
further increases SMMM risk.24 25 Yet, the aetiology of
SMMM is complex, multifaceted and time-varying. Prior
research efforts on racial/ethnic disparities in SMMM
have mostly focused on maternal and healthcare factors,26
leaving questions regarding the dynamics and interactions of multilevel determinants, such as the broader
social contexts of these risks, largely unanswered. Thus,
there is an urgent need to examine how social contexts
of all types play out in SMMM rates, especially during the
COVID-19 pandemic.22 23
South Carolina (SC) ranked 11th in COVID-19 cases per
capita as of 23 December 2021.27 Prior to the pandemic,

SC ranked 42nd in the USA in overall health and 41st
in maternal mortality.28 Births to Black women accounted
for nearly 30% of all SC births.29 Black women living in
SC experienced a twofold to threefold higher risk of
SMMM than their white counterparts.30 The majority
of counties in SC are designated medically underserved
areas.31 Considering SC’s poor health ranking, striking
racial disparities in SMMM, racially diverse population,
and historical systemic Southern contexts, SC is an ideal
environment in which to examine health disparities in
SMMM occurring during the COVID-19 pandemic.
The overarching goal of this study is to investigate
racial/ethnic disparities in SMMM, the contributing roles
and mediating pathways of social contexts (eg, structural
racism, racial discrimination), and the long-
standing
health consequences of the pandemic by studying the
distributions of COVID-19 cases and multilevel determinants of maternal health in SC and the USA. Our study
will: (1) examine the impacts of the COVID-19 pandemic
on racial/ethnic disparities in SMMM; (2) examine and
explore how the key features of social contexts (including
structural racism and racial discrimination) have contributed to the widening racial/ethnic disparities in SMMM
during the pandemic and identify distinct mediating
pathways through maternity care and mental health; and
(3) examine and identify the role of social contextual
factors and protective factors on racial/ethnic disparities in pregnancy-related long-standing morbidities (eg,
hypertension, pulmonary embolism, diabetes, cardiovascular disease), using machine learning algorithms.
METHODS AND ANALYSIS
Multilevel conceptual framework
The aetiology of racial/ethnic disparities in SMMM is
complex and multifaceted (figure 1).24 At the microlevel,
in addition to maternal race/ethnicity, other sociodemographics (eg, age, socioeconomic status (SES)), health
behaviours (eg, prenatal care adequacy, smoking, diet,
physical activity, gestational weight gain) and preexisting

Figure 1 Multilevel conceptual framework to examine racial/ethnic disparities in severe maternal morbidity and mortality in the
context of COVID-19 pandemic.
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two methods for similarities and incongruences and will
interpret findings jointly.

Figure 2 Using concurrent triangulation mixed-methods
design to investigate racial/ethnic disparities in severe
maternal morbidity and mortality during the COVID-19
pandemic. SC, South Carolina.

maternal conditions (eg, hypertension, prepregnancy
body mass index (BMI), diabetes, HIV infection,
obstetric comorbidity scores) potentially drive racial/
ethnic disparities in SMMM.12 32 33 As compared with
white women, black and Hispanic women usually have
higher poverty rates, lower educational levels, and higher
rates of pre-existing conditions or high-risk pregnancy.32
At the macrolevel, structural racism and discrimination—community and neighbourhood factors (eg, residential segregation, inadequate housing, lack of access
to healthy food, no public transportation), healthcare
institutional attributes (eg, access to risk appropriate
perinatal care) and system-level factors (eg, COVID-19
pandemic, state public health emergency policies) may
play a role in racial/ethnic disparities. These macrolevel
factors interact with microlevel factors to further exacerbate racial/ethnic disparities in SMMM.
Study design
The above-mentioned multilevel conceptual framework
guided our study design (figure 2). We will employ a
concurrent triangulation, mixed-
methods study design
to rigorously examine racial/ethnic disparities in SMMM
in SC and the USA. This convergent parallel design will
allow us to better understand the underlying mechanisms
for social contexts and racial/ethnic disparities in SMMM
via maternity care and mental health using the data
from the statewide pregnancy survey and via qualitative
interviews with pregnancy and postpartum women and
maternity care providers. Given the multilevel and multidomain nature of risk factors for pregnancy-related long-
standing morbidities, we will use novel machine learning
models to forecast the intertwining social context effects
with multilevel factors on maternal health during the
COVID-19 pandemic. We will conduct data analyses using
the quantitative and qualitative methods concurrently.
Then we will compare and contrast findings from these
Liu J, et al. BMJ Open 2022;12:e062294. doi:10.1136/bmjopen-2022-062294

Data sources
We will leverage our statewide South Carolina COVID-19
Cohort (S3C) database, which integrates COVID-
19-
related clinical, surveillance, electronic health records
(EHRs) and geospatial and temporal data at community,
healthcare institutional and system levels to comprehensively examine the roles of social contexts on racial/
ethnic disparities in SMMM. To ensure the generalisability of our findings, we will also examine them using
EHR data from the ongoing National COVID-19 Cohort
Collaborative (N3C).34 Nationwide social context databases (eg, American Community Survey (ACS), American Hospital Association (AHA)) and time-
varying
19 infection and social distancing policies
COVID-
data will be added to both S3C and N3C. Postpartum
women’s survey responses and in-depth interview data
will be analysed to understand complex pathways
and multilevel determinants of maternal morbidities
(figure 2).
SC COVID-19 Cohort-Pregnancy Database
With support from the National Institute of Allergy
and Infectious Disease (R01A127203-
4S1), our team
has established a statewide S3C database for COVID-19
research since 06/2020 by integrating various state-level
data sources including: (1) the COVID-19 testing data
from the SC Department of Health and Environmental
Control (SC DHEC), (2) hospital encounter data for
inpatient hospitalisation, outpatient surgery, home
health and emergency departments; (3) health utilisation
data from large public and private health insurance plans
(eg, Medicaid, State Health Plan, BlueCross BlueShield
of SC); (4) EHR data from health systems (Prisma and
MUSC) and (5) programme data from the SC Department of Mental Health. The database is updated every 6
months.
In this study, as part of the National Institutes of Health
(NIH)’s ‘Implementing a Maternal health and PRegnancy Outcomes Vision for Everyone’ initiative supported
5S2),
by the Office of Director, NIH (3R01A127203-
our team will create a population based S3C pregnant
women cohort (S3C-P), which includes all women who
gave birth between 2018 and 2021 in SC (>2 00 000 births,
57.2% white, 31.1% black, 4.6% Hispanic) and will add
vital record data (birth and death certificates) to complement existing linkages from the parent S3C cohort. The
identification of pregnancy status and COVID-19 infection will be cross-verified using EHR, claims data, laboratory reports and ongoing SC DHEC medical chart
reviews among >4387 pregnant women with confirmed
COVID-19 infections in SC as of December 2021. The SC
Office of Revenue and Fiscal Affairs will collate databases
and provide our team with a deidentified linked database
system.35
3
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National COVID-19 Cohort Collaborative
The N3C is a novel data consortium that integrates EHR
and medical claims data from 92 healthcare systems and
institutes across 50 states. N3C enables data sharing,
computable phenotypes and collaborative data mining
by harmonising EHR data of diverse standards using
Observational Medical Outcomes Partnership Clinical
Data Model. N3C was created to study potential risk
factors and protective factors of COVID-19 and its long-
term health consequences.34 As of 24 December 2021,
N3C has aggregated 9.4 million patients (3.3 million
COVID-
19 patients) with their EHR dating back
from January 2018, including 1.9 million women with
COVID-
19 (>61 k pregnant women) and 3.5 million
women without COVID-
19 (>209 k pregnant women).
The participants in N3C represent diverse populations in
the USA (eg, geographic, socioeconomic, racial/ethnic).
Building on a secured cloud environment, N3C provides
data harmonisation, privacy-preserving data linkage and
high-performance data analytics. Our team has already
gained access to the restricted N3C database including
ZIP codes of patients and health systems and dates of
services.
Nationwide social context databases
The 2015–2019 ACS and the 2018–2020 AHA Annual
Survey will be used to calculate county-level residential
segregation measures, racial discrimination in SES and
ZIP-level accessibility to hospital-based obstetric units.
Time-varying local COVID-19 infection and social-distancing policy
data
To better understand local pandemic settings, we will
also add the Centers for Disease Control and Prevention
(CDC) COVID-19 Case Surveillance restricted datasets
for nationwide cases confirmed since 11 March 2020,
and CDC’s state-level social distancing policies (eg, emergency declaration, stay at home order) in early pandemic
and telehealth services expansion data and each corresponding date of enaction.36
SC Pregnancy Risk Assessment Monitoring System
SC Pregnancy Risk Assessment Monitoring System
(PRAMS) as a part of national PRAMS is an ongoing
survey of SC mothers who have recently given birth.37
These mothers are sampled from state birth certificates.
After statistical weighting, PRAMS data are representative of all mothers who gave birth in SC. SC PRAMS
added 11 COVID-19-related questions for mothers who
delivered in August 2020 and after in their survey. SC
PRAMS routinely collects detailed psychosocial and
behavioural risk factors for each participant, which are
not available in S3C and N3C. Residential ZIP codes will
be used to add in social contextual variables and other
ZIP-level or county-level characteristics. The unweighted
sample size for SC 2018–2021 PRAMS will be at least
2000.
4

Key measures
Outcome measures
The main outcomes of interest will be SMMM.38 We will
adapt from a previously validated algorithm by using the
International Classification of Diseases, 10th Revision,
Clinical Modification diagnosis and procedure codes to
identify women with one or more of the 21 SMM indicators developed by the CDC and updated by the Alliance
for Innovation on Maternal Health programme at the
time of childbirth. Maternal mortality will be identified
using statewide death certificate data from the childbirth
date to up to 1-year post partum. A composite variable
of SMMM will be created to reflect SMM or maternal
mortality incidence. We will also study MMM composite,
which includes mortality and morbidities related to
hypertensive disorders of pregnancy, postpartum haemorrhage and infections/sepsis that happen during pregnancy through 6 weeks post partum.39 Other outcomes
to be studied include: (1) adverse maternal outcomes
including intensive care unit (ICU) admission, invasive ventilation, receipt of extracorporeal membrane
oxygenation, etc; (2) prolonged length of stay,40 41 and
(3) hypertension, pulmonary embolism, type 2 diabetes,
cardiovascular diseases (eg, heart attack, myocardia
infraction, thrombus, stroke) diagnosed within 1 year
after delivery.
COVID-19 status and severity
Eligible COVID-19 cases are those with a positive test
for SARS-CoV-2 since 11 March 2020, during pregnancy.
Data on symptom status (symptomatic, asymptomatic,
unknown) are available, while severity will be defined
using the WHO’s Clinical Progression Scale.42
Social context measures
The five dimensions of county-
level residential segregation, including evenness, exposure, concentration,
centralisation and clustering,43 44 will be determined for
each race/ethnic group (eg, black, Hispanic) using the
ACS Census tract data.45 46 Each index will be calculated
across census tracts within residential counties. Higher
values indicate higher levels of segregation. We will create
the group indicator for segregated vs less segregated
counties using the cutoffs for each dimension index.46
Additional hypersegregation index—segregations scores
at >0.6 on at least four aforementioned dimensions—will
be created to reflect the highest levels of segregation.46
Within-county racial/ethnic discrimination in SES will be
calculated using the ACS county data,45 including black-
white and Hispanic-
white ratios of poverty, unemployment and home ownership rates.47–51 These measures will
be linked to databases via maternal residence counties.
Healthcare institution
Using the AHA annual survey data on hospital location,52
we will identify loss of hospital-based obstetric units using
our published validated algorithm.53–55 An indicator for
whether a hospital or a hospital’s obstetric service was
Liu J, et al. BMJ Open 2022;12:e062294. doi:10.1136/bmjopen-2022-062294
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closed for each year will be created. In turn, women’s
access to hospital-
based obstetric care within 30 mile
distance for years 2018–2020 using the ArcGIS fastest
route network will be determined: (1) had access to; (2)
no access to and (3) experienced the loss of all hospital-
based obstetric units.
County-level COVID-19 infections and social distancing policies
The CDC’s COVID-19 Case Surveillance will be used to
compute monthly cumulative rates of in-county residents
that had been confirmed COVID-19 positive, hospitalised,
admitted to an ICU, and with mechanical ventilation/
intubation as a result of COVID-19 disease. Number of
months elapsed since a county had each of the following
policy orders will be calculated from a delivery date:
emergency declaration, closures of bars, restaurants and/
or other non-essential business, stay at home order and
telehealth services expansion.
Statistical analyses
Impacts of the COVID-19 pandemic on racial/ethnic disparities in
SMMM
We will examine the overall impacts of the COVID-19
pandemic on SMMM using the data from the S3C-P and
N3C. We hypothesise that: (1) compared with prepandemic periods, SMMM has increased during the pandemic
and racial/ethnic disparities have widened during the
pandemic and (2) compared with pregnant women
without COVID-
19 infection, women with COVID-
19
infection experienced higher proportions of SMMM, and
racial/ethnic disparities in SMMM have amplified among
COVID-19 infected women.
First, we will examine the distributions for all measures
and clean the database (eg, outliers, data entry errors etc)
using appropriate statistical techniques. Second, we will
conduct preliminary analyses and examine descriptive
statistics for outcome measures. Unadjusted and adjusted
associations of SMMM with key variables and covariates
will be assessed using appropriate statistical procedures
(eg, tests of proportions, χ2 tests, analysis of variance).
Women who gave birth between 1 January 2018 and
10 March 2020 will be categorised as before pandemic,
while women, who gave birth between 11 March 2020
and 31 December 2021, will be considered as during the
pandemic. The prepandemic versus pandemic impact
on SMMM will be modelled via logistic regression. First,
the crude model with the pandemic indicator only will
address SMMM change before and after the pandemic.
Second, to investigate whether racial/ethnic disparities
in SMMM have widened during the pandemic, the crude
model will be further adjusted with race/ethnicity, interactions between race/ethnicity and pandemic indicator
and months elapsed since 11 March 2020, on delivery
dates. Then additional variables will be added, including
individual-level characteristics (eg, age, SES proxy (ie,
Medicaid/uninsured status), parity, marital status, underlying health conditions). Variable selection and goodness
Liu J, et al. BMJ Open 2022;12:e062294. doi:10.1136/bmjopen-2022-062294

of model fit will be evaluated using the AIC, BIC and likelihood ratio test.
We will also conduct analyses in women who delivered
during the COVID-19 pandemic by comparing pregnant
women with and without COVID-19 infection. We will
first create the COVID-19 infection indicator and then
will perform the similar analysis as those for the prepandemic versus pandemic impact. We will further adjust for
county-level COVID-19 infections per capita and social
distancing policies at the appropriate time points using
logistic regressions with random effects accounting for
correlations among counties.
Social contexts, racial/ethnic disparities in SMMM and distinct
mediating pathways
We will study these issues using different databases and
methods. First, we will examine the association between
social contexts and changes in racial/ethnic disparities
in SMMM before and during the pandemic. We hypothesise that racial/ethnic disparities SMMM are potentially
disproportionately widened in communities with higher
racial/ethnic economic disparities (measured by black-
white ratios of economic disadvantages, Hispanic-white
ratios of economic disadvantages) and in higher vs less
segregated black or Hispanic counties (measured by residential segregation). We will conduct a parallel analysis
between social contexts and SMMM using the data from
S3C-
P and N3C (figure 2). Similarly, we will examine
the contributing roles of social contexts to racial/ethnic
disparities in SMMM in the overall sample (prepandemic vs pandemic) and between COVID-
19 positive
vs COVID-19 negative women. The multilevel variables
that will be investigated include individual-
level characteristics, community-
level characteristics (ZIP code
accessibility of hospital obstetric units), and county-level
characteristic (social contexts: residential segregation
and racial discrimination on SES; COVID-19 infection
per capita and social distancing policies). For exploratory
analysis, the OR of SMMM among black and white and
the social context level at the county level prepandemic
versus pandemic will be visualised via the spatial temporal
map using GIS. The summary statistics in SMMM with
respect to race/ethnicity will be calculated according to
individual-level and county-level characteristic.
We will model SMMM via multilevel hierarchical
logistic regression. Women who reside at the same
community-
level or county-
level will be accounted for
via random effects, which will be further modelled in
the regression model with a multivariate normal distribution to account for the correlations among community or county. We plan to use an incremental modelling
strategy: (1) crude model (race/ethnicity and social
context factors); (2) adjusting for individual level factors
and (3) additional adjustment of additional community-
level and county-levels characteristics. For N3C data, we
will further adjust for state or Census region. To further
examine whether social contexts moderate racial/ethnic
disparities in SMMM and whether these disparities vary
5
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between pre-pandemic and pandemic, we will include
two-way and three-way interaction terms in the model
(eg, pandemic period*social context*race). To examine
the added impact of COVID-19 infections on SMMM, we
will repeat the model by restricting it to all women who
gave birth during pandemic period (delivered after 11
March 2020) and including maternal COVID-19 severity
status in the model. Models will be compared using the
AIC and BIC criteria. In the modelling procedure, the
outliers, missingness, multicollinearity and non-
linear
will be addressed accordingly, and sensitivity analysis will
be conducted comparing models with or without the
treatment of outliers or missing data. The magnitude
and direction racial/ethnic disparities will be assessed
through OR and its 95% CI.
Second, we will use a convergent parallel design to evaluate the underlying pathways between social contexts and
racial/ethnic disparities in MMM via pandemic stressors,
maternity care (prenatal and postpartum) and mental
health condition. We hypothesise that social contexts
might hinder maternity care and worsen mental health
conditions among black and Hispanic women during
the pandemic and exacerbate racial/ethnic disparities in
MMM.
The quantitative analysis will be conducted using SC
PRAMS data, which have unique data elements that
are not available in S3C-P and N3C. The 2018–2021 SC
PRAMS data will provide a more refined understanding
of COVID-
19 stressors, psychosocial stress and healthcare utilisation through the questionnaire, including
pandemic stressors (financial, job loss, childcare, etc),
individual mitigation practices, changes in prenatal and
postpartum care, psychosocial stress, barriers to health
services, intimate partner violence, prenatal and postpartum care utilisation, smoking, alcohol use, gestational
weight gain and mental health. SC PRAMS asks respondents to assess how often they experienced depressive
symptoms after delivery. Descriptive statistics will be used
related changes in MMM and
to examine pandemic-
psychosocial and behavioural changes between prepandemic (delivered before 11 March 2020) and pandemic
periods (11 March 2020 and after). The weighted hierarchical regression model will be applied to examine the
association between social context and MMM. As previously mentioned, community and county levels will also
be modelled in the regression. Different from the prior
analyses above: (1) individual characteristics will mainly
come from PRAMS or birth certificates; (2) the weight
based on complex survey design will be modelled and (3)
individual reports of healthcare utilisation and mental
health condition included.
We will conduct in-depth interviews among 40 postpartum women of colour (~20 African American; ~20
Hispanic) stratified by COVID-19 infection status and 10
maternal care providers (MCPs) who serve pregnant and
postpartum women in Black and Latino communities.
The inclusion criteria of postpartum women include: (1)
≥18 years old; (2) either African American or Hispanic;
6

(3) have given birth in 2021 and (4) living in SC. We will
purposely recruit postpartum women and MCPs through
local OBGYN clinics and community health organisations
that serve a larger proportion of low-income black and
Hispanic women. We will train female interviewers of the
same race as the interviewees to obtain trust from the postpartum women participants, and interviews in Spanish
will be conducted as needed. Guided by the conceptual
framework, the main topics of the postpartum women
interviews will include: (1) their perceptions toward their
healthcare providers and institutions for perinatal care;
(2) experience with prenatal and postpartum care; (3)
stressors in the COVID-19 pandemic; (4) challenges in
healthcare seeking (eg, appointments, clinic visits), especially from structural factors (racism and discrimination)
and (5) their needs/recommendations for future healthcare. The main topics of the MCPs include: (1) stressors
and challenges of their clients; (2) clients’ mental health
conditions; (3) impacts of COVID-19 on their care provision and (4) their views on health disparities caused by
structural factors. The interviews will last 50 min and
will be recorded with each participant’s consent. Audio
recordings will be transcribed and coded using NVivo
V.11.0. We will employ thematic analyses.56 The findings
will complement the quantitative data in providing a
comprehensive picture on how COVID-19 affects psychosocial well-being of the postpartum women of colour;
offer in-depth interpretation and explanation of quantitative results; and explore the mediating pathways in which
structural factors amplify existing disparities in maternal
health in the context of the pandemic.
Machine learning-based predictive models
We will develop and evaluate machine learning-
based
predictive models to identify risk factors of SMMM and
forecast progression of hypertensive disorder, pulmonary conditions, type 2 diabetes mellitus and cardiovascular diseases among postpartum women. The predictive
models will synthesise individuals’ demographics, EHR,
social contextual factors and community and healthcare system level data to make predictions of individuals’ clinical outcomes at key time points. Because data
sources suggestive of these factors are variable and
high-dimensional, and these factors are inherently interconnected over time,57 machine learning is a superior
approach to predicting clinical outcomes and proactively
detecting the associated risk factors for early intervention
and treatment. Constructed models will demonstrate critical factors predictive of clinical outcomes and how these
factors interact over time.
Supervised machine learning algorithm will be adopted
for the predictive models. Using N3C, the algorithm
will learn from input variables and predict SMMM and
long-standing morbidities (eg, hypertension, pulmonary
embolism, diabetes, cardiovascular diseases) over time.
Input variables will include maternal characteristics, for
example, sociodemographics, sociobehavioural data,
social context variables, diagnoses, procedures, laboratory
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tests and medications. The prediction of SMMM and
long-standing morbidities will take place at critical time
points: <3, 6, 12 weeks, 6 and 12 months postpartum.58
We will develop deep learning algorithms because of
their ability to integrate complex clinical data and social
contexts from multiple sources with superior predictive performance, including: (1) convolutional neural
network (CNN) for its ability to capture dynamic patterns
among multilevel input variables; (2) recurrent neural
network (RNN) with long short-term memory (LSTM)
architecture for its ability of capturing temporal patterns
of clinical events (eg, onset of preinfection conditions,
viral infections and clinical events marked with gestational weeks, and the date of childbirths) and (3) Deep
Boltzmann Machine (DBM) for its interpretable scoring
mechanism for risk prediction.59
We will use a 10-fold cross validation. Specifically, S3C
and N3C data will each be randomly partitioned into ten
splits. In each of the 10 iterations, 7 splits of data will be
randomly selected for model training, 2 splits of data will
be used for internal validation (finetuning hyperparameters) and the 1oth split used for testing. We will use F
measure, precision, recall and the area under the receiver
operating characteristic curve, if unbalanced data, to
measure the predictive performance of models. We will
use support vector machine (SVM) as the baseline algorithm to compare against the performance of CNN, RNN
(LSTM) and DBM. The best-performed model will be
identified based on F measure.
We will rank input variables and/or clusters of input variables by calculating the importance scores57 (eg, mutual
information, SVM-
based recursive linear elimination).
Two content coinvestigators will independently review
the ranked results and identify clinical/social risk factors.
Disagreement between two reviewers will be resolved by
panel discussion. Development of sophisticated machine
learning models for predicting long-standing morbidities
will be used to identify important risk factors prenatally,
which can be used for early intervention, treatment and
community-wide interventions.
Power and sample size calculation
We estimate that there were 200 000 women who gave
birth in S3C and 270 000 pregnant women in N3C for our
study period. The primary outcome of interest is SMM
and the main exposures of interest are race (white vs
black) and pre–peri COVID-19 period. We assume that
there are 64 000 (32%) black and 114 000 (57%) white
in S3C60 and 38 070 (14.1%) black and 160 380 (59.4%)
white in N3C.61 We also assume that with the same time
length of pre and peri COVID-19, the prevalence of pregnancy will be similar (50%). For all aims, we consider the
logistic regression with mixed effects. Based on 1.5%–
2.5% incidence of SMM with 20%–50% increase due to
the COVID-19 impact or race disparities, we conduct the
power analysis based on the logistic regression using SAS
and conclude that 200 000 sample size will be adequate
to reach the power around 90%. Figure 3 illustrates the
Liu J, et al. BMJ Open 2022;12:e062294. doi:10.1136/bmjopen-2022-062294

Figure 3 Estimated power according to prevalence of
outcomes and ORs.

relationship of power and OR with setting of n=200 000,
significance at 0.05, variable of interest with a ratio of
10:90. This will be the basic model considered, and it indicates strong power for the prediction model.
Current status and anticipated timeline
As of April 2022, we have received the linked core databases for the S3C cohort for the period of January 2018–
June 2021 and full datasets will be available by the Fall
of 2022. Our team is also actively constructing N3C
analytical data of women with childbirths during January
2018–December 2021 for statistical analysis and machine
learning. Furthermore, our team is conducting in-depth
interviews with our targeted populations according to our
protocols described here. We anticipate completing our
main analyses in May 2023.
Patient and public involvement
No patients were involvement in the design, conduct
and reporting of our research. We will actively reach out
patients and public in the dissemination of our findings.

ETHICS AND DISSEMINATION
The study was approved by institutional review boards
at the University of South Carolina (Pro00115169) and
the South Carolina Department of Health and Environmental Control (DHEC IRB.21-030). Informed consent
will be completed for the participants to be enrolled in
the in-
depth interviews. Furthermore, the NIH’s N3C
data access committee approved the data use request for
this project (RP-2B9622). Study findings will be disseminated with key stakeholders including patients, presented
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at academic conferences and published in peer-reviewed
journals.
DISCUSSION
The COVID-19 pandemic has led to unprecedented societal disruptions to individuals, communities, healthcare
institutions and society. Empirical data on the scope of
possible widening racial/ethnic disparities in SMMM
during the COVID-
19 pandemic and how historical
structural racism and discrimination of all types have
impacted women of colour disproportionally are sparse.
This study will be among the first efforts to investigate
whether the COVID-19 pandemic, structural racism and
racial discrimination—exposures with broad scale and
reach—have contributed to the racial/ethnic disparities
in SMMM in the context of the COVID-19 pandemic.
Second, this proposed study employs a state-
of-
the-
art
design (ie, a convergent parallel design) to comprehensively examine the impacts of structural racism and
discrimination on maternal health and the complex pathways between multilevel determinants. This design has
the advantage of allowing us to weigh both quantitative
and qualitative methods equally and interpret the results
together.62 Third, the proposed study will innovatively use
machine learning models to predict SMMM and chronic
morbidities up to 1 year after delivery in the context of the
COVID-19 pandemic. Fourth, we propose a large-scale
population-based cohort study concurrently for both SC
and the USA, which will innovatively integrate COVID-
19-related clinical, surveillance, EHR, and geospatial data
at community, healthcare institutions and system/policy
levels. These newly integrated data sources will allow us
to examine multilevel determinants of maternal health
during the pandemic and advance the investigation
on racial/ethnic disparities in long-standing complications postpandemic. In brief, this research represents a
significant and innovative contribution to the research
on the unacceptable racial/ethnic disparities in SMMM
during pregnancy and postpartum in the context of
COVID-19. By focusing on social contextual factors (eg,
structural racism), we seek to identify ways in which the
largest number of women may be impacted by targeted
programmes and policies aiming to alter the context in
which these morbidities and mortality occur.
This study also has some limitations. First, it is possible
that the county-level social contexts’ effects in our data
may not be significant. If that happens, we will calculate ZIP-
code level social contexts. By assessing racial
segregations, spatial distribution of economic disadvantage communities within a residence county and within-
community racial discrimination, this study will provide
evidence on the associations between distinct social
contexts and maternal health disparities. Second, considering some women may move during pregnancy, the stagnant residential social contexts might not reflect their
long-term exposures to neighbourhood structural racism.
Furthermore, in the case of inferior F measures (<0.7)
8

of learning predictive models, we will apply feature selection algorithms and association rules in model training to
maximise performance.
In conclusion, the rising SMMM rate and persistent
racial/ethnic disparities should trigger public health
concerns, not only due to the immediate burden faced
by vulnerable women, but also due to potentially lasting
effects on women’s health over a life course or along
family lines across generations.63 This study will investigate racial/ethnic disparities in SMMM, the contributing
roles and mediating pathways of social contexts (eg, structural racism, racial discrimination) and the long-standing
health consequences of the pandemic by studying the
distributions of COVID-19 cases and multilevel determinants of maternal health in a racially, socioeconomically
and geographically diverse population of US pregnant
women. A rigorous examination of social contexts and
racial/ethnic disparities in SMMM during the pandemic
will contribute to the identification of factors with a broad
scale and reach for programmatic and policy interventions to alter the context in which morbidity and mortality
occur. Our findings will inform continuing efforts to
reverse the rising trends of SMMM in the USA.
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